Life
Pfizer's Lyme Vaccine Faces Regulatory Challenges Amid Promising Results
Recent findings on Pfizer's Lyme disease vaccine indicate potential efficacy but highlight significant regulatory hurdles ahead, with implications for drug supply chains.
Editorial Staff 14 days ago